Demand Analysis of Proteomics Market Overview:

Moreover, the rising incidence of various diseases, the growing demand for personalized medicines, and the increasing proteomics research activities are some of the other factors playing a pivotal role in driving the proteomics market growth. However, high cost of instruments and reagents is hindering the growth proteomics market to a certain extent.

The global proteomics market was pegged at ~US$ 21.7 billion in 2020. The market is expected to witness a CAGR of ~16.2% from 2021 to 2031.

The growing incidence of various infectious diseases and cancer has also played an important role in driving the growth of the global proteomics market. The incidence of cancer is growing across the globe. According to the World Health Organization (WHO), cancer is the second leading cause of death across the globe. According to the American Institute of Cancer Research, about 25 million new cancer cases will be diagnosed each year by 2030. These statistics highlight the rising need for early diagnosis of cancer which can effectively be achieved by applying proteomics. Thus, the rising prevalence of cancer is anticipated to drive the growth of the proteomics market.

To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/proteomics-market/7726

Key players:

Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., General Electric Company, PerkinElmer Inc., Danaher, Illumina, Inc., QIAGEN, and Eurofins Scientific, among others.

Segmentation By Product & Services:

• Instrument
• Reagent
• Software & Services

By Application:

• Clinical Diagnostics
• Drug Discovery

Regional Analysis-

• The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.
• Major factors contributing to the growth of Proteomics market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Proteomics, and increasing research activities in the field of Proteomics.
• The emergence of local players and new product launches has also played a critical role in boosting the Proteomics market in this region.

Browse the full report now: https://growthplusreports.com/report/proteomics-market/7726

Key Questions Answered in the Report Include:

(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.
(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?
(3) What are the major global Proteomics Market trends influencing the development of the market?
(4) What are the vital results of SWOT analysis of the major players operating in the Proteomics Market?
(5) What are the potential growth opportunities and threats faced by Major competitors in the market?

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.